CEGEDIM: Consolidated Turnover as at 31 December 2003.

Business Editors/Health/Medical Writers

BOULOGNE-BILLANCOURT, France--(BUSINESS WIRE)--Feb. 11, 2004

CEGEDIM Group (Paris Exchange:CGDM.PA)(Euronext:CGM)

                         CONSOLIDATED TURNOVER
                        as at 31 December 2003

                    31 Dec.      31 Dec.                  Variation
                     2003         2002                   acquisitions
 CEGEDIM GROUP      EUR'000      EUR'000     Variation     excluded
----------------- ------------ ------------ ------------ ------------

 1st Quarter           88,987       79,160           12%         6.3%
 2nd Quarter          102,256       88,840           15%         4.6%
 3rd Quarter           90,790       78,909           15%         6.4%
 4th Quarter          104,489       93,168           12%         8.1%
 Total                386,522      340,077         13.7%         6.4%

 Distribution:
 Databases, CRM
  and Marketing       223,128      196,578         13.5%         8.9%
 Pharmaceutical
  companies           189,530      162,857           16%          11%
 Direct marketing      33,598       33,721            0%           0%

 Software and IT
  Services            163,394      143,499         13.9%         3.0%
 Healthcare
  professionals        71,409       72,401           -1%          -1%
 Electronic money
  and insurances       60,251       40,392           49%          10%
 IT, management
  and the
  Internet             31,734       30,706            3%           3%

  Total               386,522      340,077         13.7%         6.4%

The CEGEDIM Group records an increase in turnover by 13.7% in 2003, with an internal growth of 6.4%, knowing that a disengagement in some activities has started.

The growth rate is notably strong within divisions achieving the highest margins. Those divisions amount to 65% of the group's consolidated turnover and both record more than 10% of internal growth.

With regard to these achievements, the consolidated operating profit should be better than expected and thus confirm the trend which has started over the first semester with growing operating margins.

'Pharmaceutical companies'

-- the 'Customer Relationship Management' business keeps on

growing successfully on the international scale: +21% of

internal growth and +32% including the MSM group acquired at

the end of September 2002. French activities achieve a

sustained growth of 5%.

-- Services in 'Information and databases' globally increase by

20% (including the CAM group since May 2002). Internal growth

stands at 11% in France and 12% for international activities

(Medimed in Germany clearly overtakes breakeven).

The 'Direct marketing' activities experience a noticeable decrease over the last quarter, compared to a good year end in 2002.

The computerization of doctors in the UK falls by 6% in 2003, with a global impact of -14% on the 'Healthcare professionals' division, due to an adverse exchange rate on the sterling pound. However, the margins have been preserved over 2003 and milestones have been established in order to allow an active cooperation, since 2004, with the 'Local Service Providers' in charge of applying the guidance of the computerization programme for Healthcare in the UK.

The French activities (amounting to 60% of the division) rise by 9% globally.

'Electronic money and insurances' activities achieve strong internal growth (+11%). The impact of the PROVAL group shall be added since April 2003.

Services in 'IT, management and the Internet' grow by 10.6 %, without taking into account the lower margin business.

Public company with share capital of 8,891,004.61 euros

Registered office: 127 a 137 rue d'Aguesseau, 92100 Boulogne Trade and Commercial

Register: Nanterre B 350 422 622